Clinical Relevance of Cerebrospinal Fluid Antibody Titers in Anti-N-Methyl-d-Aspartate Receptor Encephalitis
Open Access
- 21 December 2021
- journal article
- research article
- Published by MDPI AG in Brain Sciences
- Vol. 12 (1) , 4
Abstract
Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is the most common autoimmune encephalitis. To date, there has been no study on the relationship between antibody (Ab) titers and clinical phenotype. This study aims to clarify the relationship between cerebrospinal fluid Ab titers and clinical manifestations of anti-NMDAR encephalitis at onset. Seventy-six consecutive patients with a definite diagnosis were enrolled. The relationship between Ab titers and different onset symptoms including psychiatric symptoms, seizures, and memory deficits were analyzed. We further investigated the correlation between Ab titers and clinical severity as assessed by the modified Rankin scale (mRS) and the clinical assessment scale for autoimmune encephalitis (CASE), respectively. The Ab titers had a median value of 1:10 (range 1:1–1:100). There was no significant difference in titers among various clinical factors including gender and combination of tumor and other diseases (each p > 0.05). Patients presenting with psychiatric symptoms at onset had higher titers than those with seizures (p = 0.008) and memory deficits (p = 0.003). The mRS scores revealed a significant but weak correlation with Ab titers (r = 0.243, p = 0.034), while CASE scores did not correlate with the titers (p = 0.125). Our findings indicated that the Ab titers were associated with the type of onset symptoms, with a higher level of patients with psychiatric symptoms. Regarding the clinical severity, the titers showed a weak correlation with the mRS, but no correlation with the CASE.Keywords
Funding Information
- National Natural Science Foundation of China (82071443)
This publication has 35 references indexed in Scilit:
- Structural Hippocampal Damage Following Anti-N-Methyl-D-Aspartate Receptor EncephalitisBiological Psychiatry, 2016
- Autoantibodies in movement and psychiatric disorders: updated concepts in detection methods, pathogenicity, and CNS entryAnnals of the New York Academy of Sciences, 2015
- Cell‐surface central nervous system autoantibodies: Clinical relevance and emerging paradigmsAnnals of Neurology, 2014
- Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective studyThe Lancet Neurology, 2014
- Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort studyThe Lancet Neurology, 2013
- Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitisThe Lancet Neurology, 2011
- Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown originNeurology, 2010
- Cellular and Synaptic Mechanisms of Anti-NMDA Receptor EncephalitisThe Journal of Neuroscience, 2010
- Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesThe Lancet Neurology, 2008
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1988